Biological treatment usage in patients with HIV and rheumatic disease, 2003–2021: long-term safety and follow-up

OBJECTIVE: This study examined the safety and efficacy of biological agents, especially tumour necrosis factor (TNF) inhibitors, for HIV-positive rheumatology patients refractory to standard therapy. METHODS: This study is a retrospective case series including patients derived from a community HIV c...

Descripción completa

Detalles Bibliográficos
Autores principales: Naovarat, Benjamin Sornrung, Salazar, Gloria, Ishimori, Mariko, Williams, Francis M, Reveille, John D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310260/
https://www.ncbi.nlm.nih.gov/pubmed/35863862
http://dx.doi.org/10.1136/rmdopen-2022-002282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310260/
https://www.ncbi.nlm.nih.gov/pubmed/35863862
http://dx.doi.org/10.1136/rmdopen-2022-002282

Ejemplares similares